Advances in the treatment of HIV disease in recent years have prompted concern that individuals may regard HIV/AIDS as a less serious threat and consequently will be less committed to safer sex practices. This article reviews studies that have been conducted so far to assess the impact of new treatments for HIV on risk perceptions and behaviors among various population groups. Health practitioners need to be alerted to changing attitudes and preventive behaviors in their community stemming from the new treatments. Suggestions are offered to providers of HIV prevention services on how to address the issue of new treatments and the possibility of increasing complacency about safer sex practices.
Get full access to this article
View all access options for this article.
References
1.
Adam, P., Moreau-Gruet, F., Hamers, F., Delmas, M. C., Brunet, J. B., & Dubois-Arber, F. (1998, July). HIV/AIDS preventive attitudes and behavior of French and Swiss gay men in the era of new treatments: A comparison of two national surveys. Paper presented at the 12th International AIDS Conference, Geneva, Switzerland.
2.
Ajululuchukwu, D., Crumey, C., & Faulk, T. (1999). HIV/AIDS and prevention among college students in New York City. Paper presented at the National HIV Prevention Conference, Atlanta, Georgia.
3.
Altice, F. L., & Friedland, G. H. (1998). The era of adherence to HIV therapy. Annals of Internal Medicine, 129, 503-505.
4.
Auerbach, J. D., & Coates, T. J. (2000). HIV prevention research: Accomplishments and challenges for the third decade of AIDS. American Journal of Public Health, 90, 1029-1032.
5.
Basen-Engquist, K. (1992). Psychosocial predictors of “safer sex” behaviors in young adults. AIDS Education and Prevention, 4, 120-134.
6.
Basen-Engquist, K. (1994). Evaluation of a theory-based HIV prevention intervention for college students. AIDS Education and Prevention, 6, 412-424.
7.
Becker, M. H., & Joseph, J. (1988). AIDS and behavioral change to avoid risk: A review. American Journal of Public Health, 78, 384-410.
8.
Casseb, J., Orrico, G., Feijo, R., Guaracy, L., & Medeiros, L. (2000, July). Never use of antiretroviral therapy before hospitalization is strongly associated to death among adults with AIDS at the inst. of infectious diseases. Paper presented at the 13th International AIDS Conference, Durban, South Africa.
9.
Catz, S. L., Meredith, K. L., & Mundy, L. M. (2001). Women's HIV transmission risk perceptions and behaviors in the era of potent antiretroviral therapies. AIDS Education and Prevention, 13, 239-251.
10.
Corales, R., Taege, A., Rehm, S., & Schmitt, S. (2000, July). Regression of AIDS-related CNS lymphoma with HAART. Paper presented at the 13th International AIDS Conference, Durban, South Africa.
11.
Demmer, C. (2000). Grief and survival in the era of HIV treatment advances. Illness, Crisis & Loss, 8(1), 5-16.
12.
Demmer, C., & Caroleo, O. (2001). College students' perceptions of advances in HIV treatment and the need for safer sex practices. Psychological Reports, 88, 431-442.
13.
DiClemente, R. J. (1991). Predictors of HIV preventive sexual behavior in a high-risk adolescent population: The influence of perceived peer norms and sexual communication on incarcerated adolescents' consistent use of condoms. Journal of Adolescent Health, 12, 385-390.
14.
Elford, J., Wells, H., Sherr, L., Miller, R., Johnson, M. A., & Elford, J. (1998, July). New treatments for HIV and sexual risk behavior among people seeking an HIV test in London. Paper presented at the 12th International AIDS Conference, Geneva, Switzerland.
15.
Fatkenheuer, G., Theisen, A., Rockstroh, J., Grabow, T., Wicke, C., & Becker, K., et al. (1997). Virologic treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS, 11, F113-F116.
16.
Fleming, P. L., Wortley, P. M., Karon, J. M., DeCock, K. M., & Janssen, R. S. (2000). Tracking the HIV epidemic: Current issues, future challenges. American Journal of Public Health, 90, 1037-1041.
17.
Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., & McMahon, D., et al. (1997). Treatment with indavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. New England Journal of Medicine, 11, 734-739.
18.
Hecht, F. M., Grant, R. M., Petropoulos, C. J., Dillon, B., Chesney, M. A., & Tian, H., et al. (1998). Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. New England Journal of Medicine, 339, 307-311.
19.
Hickson, F., Reid, D. S., Henderson, L. A., Weatherburn, P., & Keogh, P. G. (1998, July). Treatment advances, risk taking and HIV testing history among gay men in the UK. Paper presented at the 12th International AIDS Conference, Geneva, Switzerland.
20.
Holzemer, W. L., Corless, I. B., Nokes, K. M., Turner, J. G., Brown, M. A., & Powell-Cope, G. M., et al. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care and STDs, 13, 185-197.
21.
Jacobson, L., Munoz, R. L., Margolick, J., Detels, R., Rinaldo, C., & Phair, J. P. (2000, July). Time to AIDS and death after starting potent antiretroviral therapy in the multicenter AIDS cohort study (MASC). Paper presented at the 13th International AIDS Conference, Durban, South Africa.
22.
Jaeger, J. E., Wolf, G., Hamme, T., Zwingers, J., Graafmans, A., & Goetzenich, H., et al. (1998. July). HAART is not hard enough—Virologic failure after 12 months of treatment in ART-naïve HIV+patients. Paper presented at the 12th International AIDS Conference, Geneva, Switzerland.
23.
Kalichman, S. C., Cherry, C., & Browne-Sperling, F. (1999). Effectiveness of a video-based motivational skills-building HIV risk-reduction intervention for inner-city African American men. Journal of Consulting and Clinical Psychology, 67, 959-966.
24.
Kalichman, S. C., Nachimson, D., Cherry, C., & Williams, E. (1998). AIDS treatment advances and behavioral prevention setbacks: Preliminary assessment of reduced perceived threat of HIV-AIDS. Health Psychology, 17, 546-550.
25.
Kalichman, S. C., Ramachandran, B., & Ostrow, D. (1998). Protease inhibitors and the new AIDS combination therapies: Implications for psychological services. Professional Psychology: Research and Practice, 29, 349-356.
26.
Kamb, M. L., Bolan, G., & Zenilman, J. (1997, July). Does HIV prevention counseling work? Results from a multi-center randomized trial (Project Respect). Paper presented at the 12th meeting of the International Society of Sexually Transmitted Diseases Research, Seville, Spain.
27.
Kelly, J. A. (2000). Behavior changes and disease prevention: MCW research shows effectiveness of HIV/AIDS risk reduction interventions. Wisconsin Medical Journal, 99, 41-43, 47.
28.
Kelly, J. A., Hoffmann, R. G., Rompa, D., & Gray, M. (1998). Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex. AIDS, 12, F91-F95.
29.
Kelly, J. A., Otto-Salaj, L. L., Sikkema, K. J., Pinkerton, S. D., & Bloom, F. R. (1998). Implications of HIV treatment advances for behavioral research on AIDS: Protease inhibitors and new challenges in HIV secondary prevention. Health Psychology, 17, 310-319.
30.
Kelly, J. A., Somlai, A. M., DiFranceisco, W. J., Otto-Salaj, L. L., McAuliffe, T. L., & Hackl, K. L., et al. (2000). Bridging the gap between science and service of HIV prevention: Transferring effective research-based HIV prevention interventions to community AIDS service providers. American Journal of Public Health, 90, 1082-1088.
31.
Kravcik, S., Victor, G., Sutherland, D., Garber, G., Hawley-Foss, N., & Angel, J. B., & et al. (1998). Effect of antiretroviral therapy and viral load on the perceived risk of HIV transmission and the need for safer sexual practices. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19, 124-129.
32.
Lert, F. (2000). Advances in HIV treatment and prevention: Should treatment optimism lead to prevention pessimism? AIDS Care, 12(6), 745-755.
33.
Malow, R. M., McPherson, S., Klimas, N., Antoni, M. H., Schneiderman, N., & Penedo, F. J., et al. (1998). Adherence to complex combination antiretroviral therapies by HIV-positive drug abusers. Psychiatric Services, 49, 1021-1022.
34.
McDonald, K., Bartos, M., Grierson, J., & de Visser, R. (2000, July). Antiretroviral treatments and HIV-positive adults' sexual practice. Paper presented at the 13th International AIDS Conference, Durban, South Africa.
35.
National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group. (1998). The NIMH multisite HIV prevention trial: Reducing HIV sexual risk behavior. Science, 280, 1889-1894.
36.
Nwokolo, E., Temprosa, L., Finkelstein, H., Lewis, R., & Jones, D. (1999). The evaluation of HIV/AIDS prevention programs: the D.C. experience. Paper presented at the National HIV Prevention Conference, Atlanta, Georgia,
37.
Prince, A., & Bernard, A. L. (1998). Sexual behaviors and safe sex practices of college students on a commuter campus. Journal of American College Health, 47, 11-22.
38.
Raveis, V. H., Blum, N., Aranda-Naranjo, B., Alexander, C., Hanna, B., & Patterson, E., et al. (2000, July). Delivering end-of-life care to individuals with HIV/AIDS: a national approach. Paper presented at the 13th International AIDS Conference, Durban, South Africa.
39.
Rosenstock, M., Strecher, V., & Becker, M. (1994). The health belief model and HIV risk behavior change. In R. DiClemente & J. Peterson (Eds.), Preventing AIDS: Theories, methods, and behavioral interventions (pp. 5-24). New York: Plenum.
40.
Roson, B. (2000, July). Risk of mortality, CMV infection and other opportunistic complications in a prospective cohort of advanced HIV-infected patients in the HAART era. Paper presented at the 13th International AIDS Conference, Durban, South Africa.
41.
Schwarcz, S. K., Hsu, L. C., Vittinghoff, E., & Katz, M. H. (2000). Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome survival in San Francisco, California, 1987-1996. American Journal of Epidemiology, 152, 178-185.
42.
Thompson, S. C., Anderson, K., Freeman, D., & Swan, J. (1996). Illusions of safety in a risky world: A study of college students' condom use. Journal of Applied Social Psychology, 26, 189-211.
43.
Vanable, P. A., Ostrow, D. G., McKirnan, D. J., Taywaditep, K. J., & Hope, B. A. (2000). Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men. Health Psychology, 19, 134-145.
44.
Vittinghoff, E., Scheer, S., O'Malley, P., Colfax, G., Holmberg, S. D., & Buchbinder, S. P. (1999). Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. Journal of Infectious Diseases, 179, 717-720.
45.
Walter, H. J., Vaughan, R. D., Gladis, M. M., Ragin, D. F., Kasen, S., & Cohall, A. T. (1992). Factors associated with AIDS risk behaviors among high school students in an AIDS epicenter. American Journal of Public Health, 82, 528-532.
46.
Williams, A. B. (1999). Adherence to highly active antiretroviral therapy. Nursing Clinics of North America, 34, 113-129.
47.
Zimmerman, M. A., Janz, N. K., & Wren, P. A. (1995). Factors influencing the success of AIDS prevention programs. In N. Freudenberg & M. A. Zimmerman (Eds.), AIDS prevention in the community. Washington, DC: American Public Health Association.
